Reviewer’ s report
Title: Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma
Version: 1Date: 24 Jan 2020
Reviewer: Tadahiko Shien
Reviewer's report:
This manuscript reported the distribution and prognosis of androgen receptor positive early breast
cancer patients. I think that this clinical question is important, but there was no new data in thismanuscript. The number of patients was too small to conclude these results. I think that theprognosis of early breast cancer patients was influenced adjuvant therapy. However, there were nodetails about them. I think that the authors should indicate the number of patients receivedadjuvant hormone therapy, chemotherapy and molecular target therapy in table 1. There weremany pathological factors in Table 1. However, some of them are not common and standardprognostic factors of breast cancer. So, the authors should explain the details of criteria of thesefactors.I think that the authors should include breast oncologist (breast surgeon or medical oncologist) asco-authors. And these oncologist should check the breast cancer treatment and prognosis in thesepatients.
Are the methods appropriate and well described?
If not, please specify what is required in your comments to the authors.
No
Does the work include the necessary controls?
If not, please specify which controls are required in your comments to the authors.
NoAre the conclusions drawn adequately supported by the data shown?
If not, please explain in your comments to the authors.
Unable to assessAre you able to assess any statistics in the manuscript or would you recommend an
additional statistical review?If an additional statistical review is recommended, please specify what aspects require furtherassessment in your comments to the editors.
Not relevant to this manuscript
Quality of written English
Please indicate the quality of language in the manuscript:
AcceptableDeclaration of competing interests
Please complete a declaration of competing interests, considering the following questions:
1. Have you in the past five years received reimbursements, fees, funding, or salary from an
organisation that may in any way gain or lose financially from the publication of this
manuscript, either now or in the future?
2. Do you hold any stocks or shares in an organisation that may in any way gain or lose
financially from the publication of this manuscript, either now or in the future?
3. Do you hold or are you currently applying for any patents relating to the content of the
manuscript?
4. Have you received reimbursements, fees, funding, or salary from an organization that holds
or has applied for patents relating to the content of the manuscript?
5. Do you have any other financial competing interests?6. Do you have any non-financial competing interests in relation to this paper?
If you can answer no to all of the above, write 'I declare that I have no competing interests' below.
If your reply is yes to any, please give details below.
I declare that I have no competing interests
I agree to the open peer review policy of the journal. I understand that my name will be included
on my report to the authors and, if the manuscript is accepted for publication, my named reportincluding any attachments I upload will be posted on the website along with the authors'responses. I agree for my report to be made available under an Open Access Creative CommonsCC-BY license (http://creativecommons.org/licenses/by/4.0/). I understand that any commentswhich I do not wish to be included in my named report can be included as confidential commentsto the editors, which will not be published.
I agree to the open peer review policy of the journal